BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36544202)

  • 1. The DEVA trial: protocol for a randomised controlled trial of dequalinium chloride versus usual care antibiotics for the treatment of bacterial vaginosis.
    Haydock R; Hepburn T; Ross J; Daniels J; Brittain C; Jackson L; Ozolins M; Wilson J
    Trials; 2022 Dec; 23(1):1040. PubMed ID: 36544202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Dequalinium Chloride vs Metronidazole for the Treatment of Bacterial Vaginosis: A Randomized Clinical Trial.
    Raba G; Durkech A; Malík T; Bassfeld D; Grob P; Hurtado-Chong A;
    JAMA Netw Open; 2024 May; 7(5):e248661. PubMed ID: 38696172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis.
    Armstrong-Buisseret L; Brittain C; David M; Dean G; Griffiths F; Hepburn T; Jackson L; Kai J; Montgomery A; Roberts T; Thandi S; Ross JDC
    Trials; 2019 Nov; 20(1):648. PubMed ID: 31775859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence.
    Vodstrcil LA; Plummer EL; Doyle M; Fairley CK; McGuiness C; Bateson D; Hocking JS; Law MG; Petoumenos K; Donovan B; Chow EPF; Bradshaw CS;
    BMC Infect Dis; 2020 Nov; 20(1):834. PubMed ID: 33176727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT.
    Armstrong-Buisseret L; Brittain C; Kai J; David M; Anstey Watkins J; Ozolins M; Jackson L; Abdali Z; Hepburn T; Griffiths F; Montgomery A; Daniels J; Manley A; Dean G; Ross JD
    Health Technol Assess; 2022 Jan; 26(2):1-170. PubMed ID: 35057905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dequalinium chloride use in adult Spanish women with bacterial vaginosis: an observational study.
    Antoni Vives J; Cancelo MJ; Losada MÁ; Doménech A
    J Obstet Gynaecol; 2022 Jan; 42(1):103-109. PubMed ID: 33629634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dequalinium for bacterial vaginosis.
    Drug Ther Bull; 2017 May; 55(5):54-57. PubMed ID: 28495833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial.
    Anstey Watkins J; Ross JDC; Thandi S; Brittain C; Kai J; Griffiths F
    PLoS One; 2019; 14(11):e0224964. PubMed ID: 31730666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety.
    Weissenbacher ER; Donders G; Unzeitig V; Martinez de Tejada B; Gerber S; Halaška M; Špaček J;
    Gynecol Obstet Invest; 2012; 73(1):8-15. PubMed ID: 22205034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of abnormal vaginal flora in Ugandan women by self-testing and short use of intravaginal antimicrobials.
    Donders G; Bellen G; Donders F; Pinget J; Vandevelde I; Michiels T; Byamughisa J
    Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):731-738. PubMed ID: 27933401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.
    Zeron Mullins M; Trouton KM
    Trials; 2015 Jul; 16():315. PubMed ID: 26210791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
    Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
    PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dequalinium Chloride for the Treatment of Vulvovaginal Infections: A Systematic Review and Meta-Analysis.
    Eckel F; Farr A; Deinsberger J; Kernmayer-Farr K; Foessleitner P
    J Low Genit Tract Dis; 2024 Jan; 28(1):76-83. PubMed ID: 38117564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review.
    Mendling W; Weissenbacher ER; Gerber S; Prasauskas V; Grob P
    Arch Gynecol Obstet; 2016 Mar; 293(3):469-84. PubMed ID: 26506926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
    BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.
    Plummer EL; Vodstrcil LA; Doyle M; Danielewski JA; Murray GL; Fehler G; Fairley CK; Bulach DM; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
    mBio; 2021 Oct; 12(5):e0232321. PubMed ID: 34663095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.
    Heczko PB; Tomusiak A; Adamski P; Jakimiuk AJ; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M; Strus M
    BMC Womens Health; 2015 Dec; 15():115. PubMed ID: 26635090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial.
    Ross JDC; Brittain C; Anstey Watkins J; Kai J; David M; Ozolins M; Jackson L; Abdali Z; Hepburn TM; Griffiths F; Montgomery A; Daniels J; Manley A; Dean G; Armstrong-Buisseret LK
    BMC Womens Health; 2023 May; 23(1):241. PubMed ID: 37161454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
    Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
    Front Immunol; 2021; 12():730986. PubMed ID: 34594336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.